MNX Global Logistics has announced the opening of its dedicated supply chain and logistics facility in Amsterdam, the Netherlands, located just outside of Amsterdam Airport Schiphol.
This facility with validated temperature-controlled supply chain capabilities will serve as the operations and warehousing hub for the firms’s life sciences and medical device customers throughout Europe.
“The demand for our services particularly in biologics, cold chain, and medical devices logistics in the EMEA region has been tremendous, and we have seen double-digit growth in the past 12 months,” said Paul J Martins, MNX chief executive officer and president. “Customers with the need for expertise in regulatory transport, strict adherence to chain of custody, visibility, control, and security of their high-value and time-critical products are turning more and more to MNX. Our investment in this new facility in Amsterdam is testament to MNX and our private equity partner, The Riverside Company’s commitment to meet the needs and exceed the expectations of our customers.”
This new facility’s capacity exceeds 1,300 square meters with the option to expand by another 1,700 square meters when needed. The HACCP- and GDP-compliant facility was designed to exceed the highest standards in the handling and movement of critical biopharmaceutical, radiopharmaceutical, and medical device shipments. It features –20 degrees C, 2-8 degrees C, and 18 degrees C temperature-controlled storage with 24/7 monitoring, backup systems, and state-of-the-art security.
Using its own dedicated GDP-compliant facility at Amsterdam allows MNX to provide on-site highly qualified and trained staff, with the ability to comply with strict standards for packaging, inventory, cross-dock, storage, and transportation for shipments.
MNX, headquartered in Irvine CA, maintains regional headquarters in Singapore, Amsterdam, and Miami FL. It serves more than 190 nations, including key Asia Pacific, South American, and EMEA markets.
Go to www.mnx.com for further information.
The Riverside Company is a global private equity firm focused on acquiring and investing in growing businesses valued at up to $300 million. Since its founding in 1988, it has invested in more than 390 transactions. The firm’s international portfolio includes more than 80 companies.
